With regular screening and follow-up care, cervical cancer is the easiest female cancer to prevent. However, current forms of testing and diagnosis are outdated and ineffective.
Transforming cervical cancer screening
Women worldwide deserve disease screening that is accessible, affordable, accurate, and comfortable.
The Pap smear, the most common screening tool for cervical cancer, is almost 100 years old. It’s also expensive, painful, time-consuming from sample to diagnosis, and employs antiquated technology.
is the smart solution.
No laboratory work required
Combining advanced spectroscopy methods with data insights and Artificial Intelligence algorithms, HeraFem delivers accurate cervical cancer diagnoses in real-time.
HeraFem is the future in cervical cancer diagnostics.